COSRX

COSRX is a South Korean skincare company based in the Gangnam district of Seoul. The brand builds ingredient-focused, solution-based products for sensitive and acne-prone skin, and its name is a contraction of "Cosmetics" and "RX," the abbreviation for a medical prescription. Officially founded as COSRX in 2013 [8], it grew over the following decade into one of the most widely distributed K-beauty brands, reaching markets in well over a hundred countries.

Since 2021 the company has been progressively absorbed by the Korean cosmetics group Amorepacific, which raised its holding to a controlling 93.2% in a deal announced in October 2023 and completed in 2024 [7]. COSRX continues to operate and launch products under its own name as an Amorepacific subsidiary.

According to editorial coverage, COSRX was founded by Jeon Sanghoon, an experienced cosmetics producer whose own sensitive skin did not respond well to the treatments available on the market [8][9]. That personal frustration is cited as the starting point for a brand organised around gentle, ingredient-led formulas for difficult skin. One account describes the approach as "a deep focus on textures, gentle skincare and implementing ingredients that work at the core of each product." The founder's name is romanised inconsistently across sources: some profiles give it as Jeon Sanghoon [8], while other coverage renders the same person as Jun Sang Hun [9].

The brand dates its founding to 2013, but its own About Us page frames that within a longer timeline, stating it has been "operating since 2002" and was "officially founded as COSRX in 2013" [3]. The 2002 date reflects predecessor cosmetic operations rather than the COSRX brand itself, which is consistently recorded as a 2013 foundation across the company, Amorepacific and editorial sources [7][8].

The name encodes the brand's positioning. The company explains it as a fusion of "Cosmetics" and "RX," the shorthand for a prescription, expressing an intent to treat skincare as a targeted, problem-solving discipline rather than a purely cosmetic one. The corporate entity is registered in Korea as COSRX INC. and operates from offices on Teheran-ro in Gangnam, Seoul.

The company's first product was the BHA Blackhead Power Liquid, an exfoliating treatment built around salicylic acid to clear excess skin cells and sebum from pores. In 2014 it quietly launched its Advanced Snail line, formulated around snail secretion filtrate; editorial accounts describe products that spread largely by word of mouth before gaining sharp international momentum. One source recounts that the line arrived "without much fanfare," with users adopting it gradually before demand climbed steeply, and describes the brand being "suddenly demanded into every corner of the world" as online interest accelerated — a trajectory tied to the broader 2010s K-beauty wave.

By 2018 COSRX had entered Amazon in North America, where the Advanced Snail 96 Mucin Power Essence reached the top of the regional Beauty and Personal Care category. The company reports supplying more than 146 countries [3]; a press account places its reach at roughly 140 markets spanning North America, Southeast Asia, Europe and Japan, with overseas sales accounting for more than 90% of the total [7].

The brand's commercial scale is reflected in figures disclosed around the Amorepacific transaction. COSRX recorded 204.4 billion won in sales in 2022, and 190.2 billion won in sales with 71.7 billion won in operating profit in the first half of 2023, against a three-year average annual growth rate above 60% [7]. Editorial coverage adds that several of the brand's products had together accumulated more than 100,000 five-star reviews.

COSRX is a subsidiary of Amorepacific Corporation, the Seoul-based cosmetics group that lists it among more than thirty beauty, personal-care and health brands alongside names such as Sulwhasoo, Laneige, Etude, Innisfree and Aestura [6]. Amorepacific first took a 38.4% stake in COSRX in September 2021. In October 2023 it announced the exercise of a call option granted in 2021, acquiring additional shares in a transaction valued at 755.1 billion won and lifting its ownership to 93.2%; the deal incorporated COSRX as a subsidiary, with completion recorded in 2024 [7]. Amorepacific's chief executive, Seunghwan Kim, attributed the brand's appeal to "rapid growth through differentiated products and marketing based on an exceptional understanding of digital channels."

COSRX builds its identity on the idea, stated on its own site, that "cosmetics should give more than just outward beauty," presenting its work as helping individuals find solutions tailored to their personal skin conditions. The company frames its mission, in editorial coverage, as becoming "the best hypoallergenic skincare brand for those with sensitive skin." Its stated values centre on simple, effective ingredients, gentle formulation and an affordable price point, and its products sit in the drugstore tier rather than the luxury one. The brand describes its formulas as "skin-friendly, clinically tested" and curated by skin concern.

That positioning targets people with sensitive, acne-prone skin who want straightforward, affordable solutions. The company organises its catalogue around concerns — fine lines and wrinkles, acne and breakouts, dryness, pores and oil control, dullness, and redness and sensitivity — and presents a basic three-step routine of cleansing and prep, targeted treatment, and protection with moisturiser and sunscreen. On the research side, the company says it studies ingredients and formulations in its own laboratory, which it calls the RX Studio or COSRX Lab, developing products around the interplay of product type, skin concern and ingredient.

The range is built around a set of recognised active ingredients, including snail mucin, salicylic acid (BHA), AHA, niacinamide, hyaluronic acid, peptides, PDRN, ceramides, vitamin C and retinol. Several products are repeatedly cited as the brand's signatures:

- Advanced Snail 96 Mucin Power Essence, described in editorial coverage as a best-seller on Amazon US and marketed by the company as a leading K-beauty essence. - Low pH Good Morning Gel Cleanser, reported to have sold more than eight million units worldwide. - Acne Pimple Master Patch, a hydrocolloid spot patch that editorial coverage credits COSRX with helping popularise; one source states that one is sold every 25 seconds. - Advanced Snail 92 All-in-One Cream, part of the same snail-based line. - BHA Blackhead Power Liquid, the brand's original 2013 product, a salicylic-acid exfoliant.

Beyond these, the company markets a premium active-ingredient range it calls The RX, alongside a ceramide-based barrier moisturiser and peptide serums. It has extended past facial skincare into hair and body care, marketing a patented hair-bonding technology it calls PEPTIDE-132. Newer additions shown on its stores include a 5 PDRN line, drawing on the repair ingredient polydeoxyribonucleotide, and a Blue Peptide Bakuchiol range pairing peptides with bakuchiol. Across its marketing the brand associates itself with the "glass skin" aesthetic popular in K-beauty.

The company states on its About Us page that it won 119 Global Beauty Awards between 2014 and 2021 [3]. Its snail-based essence and pimple patch are frequently referenced in beauty press as widely adopted products of the 2010s K-beauty wave.

COSRX is an active, majority-owned subsidiary of Amorepacific. It continues to sell globally and to introduce new product lines under its own name, with recent launches such as its 5 PDRN and Blue Peptide Bakuchiol ranges appearing on its official stores. Its status is best described as acquired rather than independent: the brand operates much as before, but ownership and control rest with Amorepacific following the 2021–2024 stake acquisitions.